Kamada LtdNASDAQ:KMDA
- LAST PRICE4.8300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.7800/ 1
- Ask / Lots5.8700/ 25
- Open / Previous Close4.8000 / 4.8300
- Day Range
- 52 Week Range
- Volume51,389
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KMDA |
|---|---|---|
| 09:32 ET | 7451 | 4.86 |
| 09:34 ET | 600 | 4.86 |
| 09:43 ET | 140 | 4.86 |
| 09:48 ET | 622 | 4.8401 |
| 09:54 ET | 320 | 4.855 |
| 10:12 ET | 100 | 4.88 |
| 10:24 ET | 300 | 4.8758 |
| 10:26 ET | 500 | 4.87 |
| 10:28 ET | 300 | 4.89 |
| 10:32 ET | 126 | 4.9128 |
| 11:02 ET | 576 | 4.87 |
| 11:08 ET | 100 | 4.87 |
| 11:13 ET | 100 | 4.87 |
| 11:15 ET | 100 | 4.87 |
| 11:22 ET | 200 | 4.87 |
| 11:27 ET | 200 | 4.87 |
| 11:31 ET | 100 | 4.87 |
| 11:36 ET | 200 | 4.87 |
| 11:40 ET | 2650 | 4.81 |
| 11:44 ET | 200 | 4.822 |
| 11:47 ET | 100 | 4.8105 |
| 11:54 ET | 100 | 4.81 |
| 11:58 ET | 100 | 4.81 |
| 12:00 ET | 100 | 4.81 |
| 12:07 ET | 1988 | 4.83 |
| 12:09 ET | 1186 | 4.81 |
| 12:18 ET | 100 | 4.82 |
| 12:21 ET | 800 | 4.83 |
| 12:23 ET | 1999 | 4.8399 |
| 12:27 ET | 1400 | 4.84 |
| 12:30 ET | 200 | 4.85 |
| 12:48 ET | 100 | 4.85 |
| 01:01 ET | 600 | 4.86 |
| 01:21 ET | 100 | 4.85 |
| 01:30 ET | 100 | 4.85 |
| 01:48 ET | 100 | 4.84 |
| 01:55 ET | 100 | 4.84 |
| 01:57 ET | 700 | 4.85 |
| 02:02 ET | 100 | 4.84 |
| 02:22 ET | 940 | 4.84 |
| 02:24 ET | 582 | 4.84 |
| 02:26 ET | 100 | 4.84 |
| 02:27 ET | 600 | 4.85 |
| 02:29 ET | 100 | 4.84 |
| 02:33 ET | 100 | 4.82 |
| 02:40 ET | 300 | 4.82 |
| 02:47 ET | 100 | 4.81 |
| 02:54 ET | 100 | 4.81 |
| 03:00 ET | 100 | 4.82 |
| 03:07 ET | 100 | 4.81 |
| 03:23 ET | 3500 | 4.8428 |
| 03:30 ET | 100 | 4.84 |
| 03:39 ET | 100 | 4.84 |
| 03:50 ET | 100 | 4.84 |
| 03:52 ET | 1570 | 4.84 |
| 03:54 ET | 700 | 4.82 |
| 03:56 ET | 1700 | 4.83 |
| 03:57 ET | 1140 | 4.83 |
| 03:59 ET | 2092 | 4.83 |
May 24, 2023
BRIEF-Kamada Announces $60 Million Private Placement With Fimi Opportunity Funds, from 8:07AM ET on Wednesday May 24, 2023 by Thomson Reuters
8:07AM ET on Wednesday May 24, 2023 by Thomson ReutersKamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue and Profitability Guidance, from 7:10AM ET on Wednesday May 24, 2023 by GlobeNewswire
7:10AM ET on Wednesday May 24, 2023 by GlobeNewswireKamada Announces Chief Financial Officer Chaime Orlev to Remain in Role and Appointment of Nir Livneh as Vice President, General Counsel and Corporate Secretary, from 7:05AM ET on Wednesday May 24, 2023 by GlobeNewswire
7:05AM ET on Wednesday May 24, 2023 by GlobeNewswireKamada Announces $60 Million Private Placement with FIMI Opportunity Funds, from 7:00AM ET on Wednesday May 24, 2023 by GlobeNewswire
7:00AM ET on Wednesday May 24, 2023 by GlobeNewswire
May 17, 2023
Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023, from 7:00AM ET on Wednesday May 17, 2023 by GlobeNewswire
7:00AM ET on Wednesday May 17, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kamada Ltd | 214.3M | -94.0x | --- |
Poseida Therapeutics Inc | 210.0M | -4.2x | --- |
Rigel Pharmaceuticals Inc | 243.1M | -5.5x | --- |
Codexis Inc | 175.6M | -3.6x | --- |
Sangamo Therapeutics Inc | 197.6M | -1.4x | --- |
Selecta Biosciences Inc | 196.4M | -13.6x | --- |
Company Information
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Contact Information
- Headquarters
- 2 Holtzman St., Science ParkREHOVOT, Israel 7670402
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Lilach Asher Topilsky
- Chief Executive Officer
- Amir London
- Deputy Chairman of the Board
- David Tsur
- Chief Financial Officer
- Chaime Orlev
- Senior Vice President - Scientific Affairs
- Ruth Wolfson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $214.3M |
|---|---|
Revenue (TTM) | $132.0M |
Shares Outstanding | 44.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.98 |
EPS | $-0.05 |
Book Value | $3.93 |
P/E Ratio | -94.0x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | 21.5x |
Operating Margin | 3.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
